Crystalline forms of phthalazinone compound
Abstract:
The present specification provides crystalline forms of 4-[3-(3-[(cyclopropylamino)methyl]azetidine-1-carbonyl)-4-fluorobenzyl]phthalazin-1(2H)-one hydrochloride, methods of preparing the same, and pharmaceutical compositions comprising the same.
Public/Granted literature
Information query
Patent Agency Ranking
0/0